These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31313364)

  • 41. Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C.
    Fraquelli M; Rigamonti C; Casazza G; Donato MF; Ronchi G; Conte D; Rumi M; Lampertico P; Colombo M
    J Hepatol; 2011 Apr; 54(4):621-8. PubMed ID: 21146243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Noninvasive assessment of liver steatosis, fibrosis and inflammation in chronic hepatitis C virus infection.
    Schneider AR; Teuber G; Kriener S; Caspary WF
    Liver Int; 2005 Dec; 25(6):1150-5. PubMed ID: 16343065
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis.
    Fung J; Lai CL; Chan SC; But D; Seto WK; Cheng C; Wong DK; Lo CM; Fan ST; Yuen MF
    Am J Gastroenterol; 2010 May; 105(5):1116-22. PubMed ID: 19920809
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.
    Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A
    Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C.
    Tsochatzis E; Papatheodoridis GV; Manesis EK; Chrysanthos N; Kafiri G; Archimandritis AJ
    Dig Liver Dis; 2007 Oct; 39(10):936-42. PubMed ID: 17720637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.
    Peng D; Han Y; Ding H; Wei L
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1082-8. PubMed ID: 18707599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Viral and host causes of fatty liver in chronic hepatitis B.
    Altlparmak E; Koklu S; Yalinkilic M; Yuksel O; Cicek B; Kayacetin E; Sahin T
    World J Gastroenterol; 2005 May; 11(20):3056-9. PubMed ID: 15918189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acoustic radiation force impulse elastography, FibroScan®, Forns' index and their combination in the assessment of liver fibrosis in patients with chronic hepatitis B, and the impact of inflammatory activity and steatosis on these diagnostic methods.
    Dong DR; Hao MN; Li C; Peng Z; Liu X; Wang GP; Ma AL
    Mol Med Rep; 2015 Jun; 11(6):4174-82. PubMed ID: 25651500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of steatosis on liver stiffness measurement in patients with chronic hepatitis B.
    Kim SU; Kim DY; Ahn SH; Kim HM; Lee JM; Chon CY; Park YN; Han KH; Park JY
    Hepatogastroenterology; 2010; 57(101):832-8. PubMed ID: 21033238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Sánchez-Conde M; Montes Ramírez ML; Bellón Cano JM; Caminoa A; Alvarez Rodríguez F; González Garcia J; Miralles Martín P; Bernardino de la Serna I; Bernardo de Quirós JC; Arribas López JR; Cosín Ochaíta J; Pascual Pareja JF; Alvarez E; Berenguer JB
    J Viral Hepat; 2011 Jul; 18(7):e278-83. PubMed ID: 21129129
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Impact of liver steatosis on the curative effect of pegylated interferon-alpha-2a in patients with chronic hepatitis B].
    Xu L; Li P; Shi Q; Mi Y
    Zhonghua Gan Zang Bing Za Zhi; 2015 Feb; 23(2):99-102. PubMed ID: 25880974
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C.
    Zaitoun AM; Al Mardini H; Awad S; Ukabam S; Makadisi S; Record CO
    J Clin Pathol; 2001 Jun; 54(6):461-5. PubMed ID: 11376020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of hepatic steatosis index, controlled attenuation parameter and ultrasound as noninvasive diagnostic tools for steatosis in chronic hepatitis B.
    Xu L; Lu W; Li P; Shen F; Mi YQ; Fan JG
    Dig Liver Dis; 2017 Aug; 49(8):910-917. PubMed ID: 28433586
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic Steatosis and its Effects on Fibrosis in Patients With Chronic Hepatitis B Virus Infection.
    Garcia-Saenz-de-Sicilia M; Duarte-Rojo A
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):491-494. PubMed ID: 29248735
    [No Abstract]   [Full Text] [Related]  

  • 55. Sonography Predicts Liver Steatosis in Patients With Chronic Hepatitis B.
    Kelly EM; Feldstein VA; Etheridge D; Hudock R; Peters MG
    J Ultrasound Med; 2017 May; 36(5):925-932. PubMed ID: 28151547
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Steatosis and serum lipid patterns in patients with chronic viral hepatitis: differences related to viral etiology.
    Vere CC; Neagoe D; Streba CT; Prejbeanu I; Ianoşi G; Comănescu V; Pirici D
    Rom J Morphol Embryol; 2010; 51(3):509-14. PubMed ID: 20809028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters.
    Rastogi A; Sakhuja P; Kumar A; Hissar S; Jain A; Gondal R; Sarin SK
    Indian J Pathol Microbiol; 2011; 54(3):454-9. PubMed ID: 21934202
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
    Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
    Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
    Yu JH; Lee JW
    Clin Mol Hepatol; 2019 Sep; 25(3):280-282. PubMed ID: 30661335
    [No Abstract]   [Full Text] [Related]  

  • 60. Impact of non-alcoholic fatty liver disease on chronic hepatitis B.
    Bondini S; Kallman J; Wheeler A; Prakash S; Gramlich T; Jondle DM; Younossi ZM
    Liver Int; 2007 Jun; 27(5):607-11. PubMed ID: 17498244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.